Tagged Articles

cancer deaths 4 articles

Pancreatic cancer expected to become second leading cause of cancer related deaths

Pancreatic cancer will likely be the second most common cause of cancer deaths in the United States by 2030, overtaking breast and colon cancer deaths, according to a new report by the Pancreatic Cancer Action Network (PCAN). Currently, the top three causes of cancer-related death in the United States are lung, colorectal and breast cancers followed by pancreatic, prostate and liver cancers. Lung is expected to remain the top cancer killer in 2013, but pancreatic cancer is expected to move into second place. The reason, the group explains, is partly due to changes in demographics, such as an increase in ... Read More

Study links insulin therapy to bladder cancer deaths in diabetics

Type 2 diabetics on insulin therapy are more likely to die from bladder cancer than those using other treatments, a new study suggests. Researchers with the Department of Internal Medicine at the National Taiwan University College of Medicine in Taipei, followed more than 86,000 patients with type 2 diabetes aged 25 or older from 1995 through 2006 for bladder cancer deaths. They concluded that patients who used insulin to keep their blood sugar levels in check were nearly twice as likely to die from bladder cancer compared to those who did not use insulin. Patients who used insulin and who ... Read More

New study finds HRT increases women’s risk for kidney stones

Hormone replacement therapy (HRT) is blamed for increasing a woman’s risk of breast and ovarian cancer, heart attacks and strokes. Now, a new research study shows the pills also increase women’s risk of developing painful kidney stones. The landmark government research studied 24,000 postmenopausal women taking either HRT or placebo, and found that women on HRT were 21 percent more likely to develop kidney stones over a five-year period. The risks were equal among women taking Prempro, pills containing estrogen plus progestin, and Premarin, estrogen-only pills. Comparatively, studies show that overall about 6 percent of postmenopausal women develop kidney stones. ... Read More

FDA investigates link between blood pressure drugs and cancer

The Food and Drug Administration (FDA) is investigating a recently published study that suggests medications used to treat high blood pressure and other conditions, known as angiotensin receptor blockers (ARBs), may increase cancer risk. Brand name ARBs include Atacand, Avapro, Benicar, Cozaar, Diovan, Micardis, and Teveten. The published meta-analysis combined data from more than 60,000 patients in several long-term, randomized, controlled clinical trials evaluating ARBs during which adverse events related to cancer were captured. New cancer occurrence was 7.2 for patients receiving ARBs compared to 6.0 for patients not receiving ARBs. No statistically significant difference in cancer deaths were reported. ... Read More